Analyze Diet

Topic:Anti-thrombotic Therapy

Anti-thrombotic therapy in horses involves the use of medications or interventions to prevent or treat thrombosis, which is the formation of blood clots within blood vessels. Thrombosis can lead to significant health issues in horses, including impaired circulation and tissue damage. Common anti-thrombotic agents used in equine medicine include anticoagulants like heparin and antiplatelet drugs such as aspirin. These therapies aim to reduce the risk of clot formation by interfering with various pathways in the blood coagulation process. Monitoring and managing the balance between preventing thrombosis and avoiding excessive bleeding is a critical aspect of treatment. This page compiles peer-reviewed research studies and scholarly articles that explore the mechanisms, efficacy, and safety of anti-thrombotic therapies in equine patients.
Interaction of horse plasma antithrombin III and alpha 1-proteinase inhibitor with some serine proteinases.
Acta biologica et medica Germanica    January 1, 1981   Volume 40, Issue 10-11 1561-1570 
Koj A, Kurdowska A.Antithrombin III and alpha 1-proteinase inhibitor isolated simultaneously from horse citrated plasma were tested for inhibitory activity against bovine trypsin and chymotrypsin, as well as elastase-like neutral proteinases from horse leucocytes. The stoichiometry of reaction and kinetic parameters (kass, Ko) were estimated and related to the protein pattern obtained after exposure of these proteinases to horse inhibitors as analyzed by polyacrylamide gel electrophoresis (PAGE and PAGE-SDS). As shown by fast reaction rates and low values of dissociation constants the two inhibitors effectively ...
Warfarin anticoagulation in the horse.
Journal of the American Veterinary Medical Association    December 1, 1980   Volume 177, Issue 11 1146-1151 
Scott EA, Byars TD, Lamar AM.The hematologic and clinical effects of anticoagulation with warfarin were documented in 4 horses. All of the animals had thrombophlebitis (external jugular vein). Measures of coagulation were monitored, with a prothrombin time of 1.5 to 2.5 x base-line value being used as the effective range of anticoagulation. Recanalization was achieved in 2 of 4 cases. Hemorrhage, both subcutaneous and through a surgical incision, was a complication. Vitamin K1, an antidote to warfarin toxicosis, was administered intravenously to reverse anticoagulation and to control hemorrhage.
The diagnosis, management and treatment of bleeding disorders. Part 2.
Modern veterinary practice    September 1, 1977   Volume 58, Issue 9 756-762 
Dodds WJ.No abstract available
Characterization of human, bovine, and horse antithrombin III.
Biochemistry    January 27, 1976   Volume 15, Issue 2 368-373 doi: 10.1021/bi00647a020
Kurachi K, Schmer G, Hermodson MA, Teller DC, Davie EW.A comparison of the physical-chemical properties of human, bovine, and horse antithrombin III has been made. These three plasma proteins are strong inhibitors of bovine factor Xa and form a 1:1 molar complex with this coagulation enzyme. Human, bovine, and horse antithrombin III are glycoproteins containing hexose, hexosamine, and neuraminic acid. The total carbohydrate was 9, 12, and 16% for human, bovine, and horse antithrombin III, respectively. These proteins have a similar amino acid composition, although some monor variations were noted. Each antithrombin III is composed of a single poly...
Diarrhoea in horses associated with ulceration of the colon and caecum resulting from S vulgaris larval migration.
The Veterinary record    September 20, 1975   Volume 97, Issue 12 221-225 doi: 10.1136/vr.97.12.221
Greatorex JC.The clinical manifestations of a diarrhoeic syndrome of horses with ulceration of the mucosae of the colon and caecum are described. Patients could be divided into three groups according to their presenting symptoms and the disease is probably caused by the thrombo-embolism associated with migrating larvae of Strongylus vulgaris. The differential diagnosis, prognosis and treatment are outlined with particular reference to the use of antithrombotic agents.
Anticoagulant activity of equine follicular fluid.
Journal of reproduction and fertility    April 1, 1962   Volume 3 269-282 doi: 10.1530/jrf.0.0030269
STANGROOM JE, de WEEVERS RG.No abstract available
Heparin and thromboplastin generation in the horse.
Nature    January 24, 1959   Volume 183, Issue 4656 235-236 doi: 10.1038/183235a0
ARCHER RK, FLUTE P.No abstract available